These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 17631146
1. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, Fava G, Francis H, Trozzi L, Glaser S, Benedetti A. Gastroenterology; 2007 Jul; 133(1):244-55. PubMed ID: 17631146 [Abstract] [Full Text] [Related]
2. Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis. Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, Fava G, Francis H, Trozzi L, Benedetti A. Gut; 2009 Jul; 58(7):990-7. PubMed ID: 18829977 [Abstract] [Full Text] [Related]
3. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T. Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053 [Abstract] [Full Text] [Related]
4. Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. Marzioni M, Saccomanno S, Candelaresi C, Rychlicki C, Agostinelli L, Shanmukhappa K, Trozzi L, Pierantonelli I, De Minicis S, Benedetti A. J Hepatol; 2010 Oct; 53(4):663-70. PubMed ID: 20621380 [Abstract] [Full Text] [Related]
5. Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms. Glaser S, Benedetti A, Marucci L, Alvaro D, Baiocchi L, Kanno N, Caligiuri A, Phinizy JL, Chowdury U, Papa E, LeSage G, Alpini G. Hepatology; 2000 Jul; 32(1):17-25. PubMed ID: 10869284 [Abstract] [Full Text] [Related]
7. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A. Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271 [Abstract] [Full Text] [Related]
8. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis. Fan R, Li X, Gu X, Chan JC, Xu G. Diabetes Obes Metab; 2010 Sep; 12(9):815-24. PubMed ID: 20649634 [Abstract] [Full Text] [Related]
9. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose. Burmeister MA, Ayala J, Drucker DJ, Ayala JE. Am J Physiol Endocrinol Metab; 2013 Apr 01; 304(7):E677-85. PubMed ID: 23341495 [Abstract] [Full Text] [Related]
10. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis. Baggio LL, Huang Q, Cao X, Drucker DJ. Gastroenterology; 2008 Apr 01; 134(4):1137-47. PubMed ID: 18313669 [Abstract] [Full Text] [Related]
11. Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently. Cheong YH, Kim MK, Son MH, Kaang BK. Biochem Biophys Res Commun; 2012 Jan 06; 417(1):558-63. PubMed ID: 22177947 [Abstract] [Full Text] [Related]
13. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice. Jin CH, Chae SY, Son S, Kim TH, Um KA, Youn YS, Lee S, Lee KC. J Control Release; 2009 Feb 10; 133(3):172-7. PubMed ID: 18977255 [Abstract] [Full Text] [Related]
14. Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner. Zhao H, Wei R, Wang L, Tian Q, Tao M, Ke J, Liu Y, Hou W, Zhang L, Yang J, Hong T. Am J Physiol Endocrinol Metab; 2014 Jun 15; 306(12):E1431-41. PubMed ID: 24801389 [Abstract] [Full Text] [Related]
15. Immunohistochemical features of bile duct epithelial cells in normal and experimental liver conditions. Onori P, Franchitto A, Alvaro D, Gaudio E. Ital J Anat Embryol; 2001 Jun 15; 106(2 Suppl 1):371-8. PubMed ID: 11729979 [Abstract] [Full Text] [Related]
16. Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia. Lee CH, Yan B, Yoo KY, Choi JH, Kwon SH, Her S, Sohn Y, Hwang IK, Cho JH, Kim YM, Won MH. J Neurosci Res; 2011 Jul 15; 89(7):1103-13. PubMed ID: 21472764 [Abstract] [Full Text] [Related]
17. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro. Dalvi PS, Nazarians-Armavil A, Purser MJ, Belsham DD. Endocrinology; 2012 May 15; 153(5):2208-22. PubMed ID: 22334721 [Abstract] [Full Text] [Related]
18. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor. Ban K, Kim KH, Cho CK, Sauvé M, Diamandis EP, Backx PH, Drucker DJ, Husain M. Endocrinology; 2010 Apr 15; 151(4):1520-31. PubMed ID: 20172966 [Abstract] [Full Text] [Related]
19. Real-time trafficking and signaling of the glucagon-like peptide-1 receptor. Roed SN, Wismann P, Underwood CR, Kulahin N, Iversen H, Cappelen KA, Schäffer L, Lehtonen J, Hecksher-Soerensen J, Secher A, Mathiesen JM, Bräuner-Osborne H, Whistler JL, Knudsen SM, Waldhoer M. Mol Cell Endocrinol; 2014 Feb 15; 382(2):938-49. PubMed ID: 24275181 [Abstract] [Full Text] [Related]
20. Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor. Nuche-Berenguer B, Portal-Núñez S, Moreno P, González N, Acitores A, López-Herradón A, Esbrit P, Valverde I, Villanueva-Peñacarrillo ML. J Cell Physiol; 2010 Nov 15; 225(2):585-92. PubMed ID: 20506394 [Abstract] [Full Text] [Related] Page: [Next] [New Search]